Stocks
Arcus Biosciences, Inc.RCUS
NYSEHealthcareBiotechnology$22.12
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing cancer immunotherapies, including investigational drugs targeting TIGIT and CD73 pathways. Its pipeline focuses on combination treatments for solid tumors, and investors track it for its partnerships with larger pharmaceutical firms and its progress in late-stage trials.
52W Range: $16.04-$31.73
Congressional Interest in Arcus Biosciences, Inc. (RCUS)
No congressional trades have been disclosed for Arcus Biosciences, Inc. (RCUS) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading RCUS?
No congressional trades found for this stock.